semaglutide contraindications pancreatitis Updates in Medicine | Not just weight loss anymore — is now part of cardiovascular risk reduction. 🫀 Semaglutide and Type 2 Diabetes

After 'The Wall Street Journal' interviewed parents using GLP-1 weight-loss drugs to help children as young as nine struggling with obesity, The...

Novo Nordisk will cut prices of the diabetes and weight loss drugs Ozempic, Rybelsus and Wegovy to $675 effective Jan

(NASDAQ:AMGN) collaboration

Medicaid coverage for GLP-1 medications differs significantly by state, with most programs requiring documented obesity-related conditions or failed prior weight-loss attempts

Explore options for advanced vein treatments in Michigan, North Carolina, & South Carolina

Obesity affects 42% of adults in the United States and is strongly associated with major cardiovascular disease risk factors, including high blood pressure, abnormal cholesterol levels, and insulin resistance, making effective obesity treatment a critical public health priority.